Literature DB >> 10999063

Clinico-hematological spectrum of auto-immune hemolytic anemia: an Indian experience.

V P Choudhry1, G R Passi, H P Pati.   

Abstract

Twenty-one patients of autoimmune hemolytic anemia (AIHA), aged 2 months to 57 years were analyzed. The common presenting feature was pallor (89%), fever (38%), Jaundice (43%) and hepatomegaly and splenomegaly was seen in 76% and 81% respectively. Fifteen cases were of idiopathic etiology and in 6 cases the etiology could be identified as systemic lupus erythematosus, systemic sclerosis, pregnancy, maternal AIHA, typhoid fever and myelodysplastic syndrome (one each). Hemoglobin level ranged between 1.9 to 11.7 gm/dl (mean 6.8 gm/dl) and reticulocyte counts between 6% to 42% (mean (20.2%). Four patients had thrombocytopenia. Direct antiglobulin test (DAT) was positive in 19 and indirect antiglobulin test (IAT) in 7 cases. There was no correlation between DAT positivity and severity of anemia. All patients had warm antibodies of IgG type. Ten of fourteen patients responded to steroid therapy. Patients with secondary AIHA had a significantly poorer prognosis compared to the idiopathic group.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10999063

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  4 in total

1.  Abdominal tuberculosis with autoimmune hemolytic anemia.

Authors:  V Gupta; B D Bhatia
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

2.  Autoimmune hemolytic anemia.

Authors:  V Gupta; J Shukla; B D Bhatia
Journal:  Indian J Pediatr       Date:  2008-06-08       Impact factor: 1.967

3.  Disease-modifying treatments for primary autoimmune haemolytic anaemia.

Authors:  Anthony Pak-Yin Liu; Daniel Kl Cheuk
Journal:  Cochrane Database Syst Rev       Date:  2021-03-26

4.  Clinical patterns and hematological spectrum in autoimmune hemolytic anemia.

Authors:  Vanamala Alwar; Devi A M Shanthala; S Sitalakshmi; R K Karuna
Journal:  J Lab Physicians       Date:  2010-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.